Cited by 574Asthma and respiratory diseasesOccupational exposure and asthmaRespiratory and Cough-Related Research

The DOI matches its Crossref record.

Alternative excitotoxic hypotheses

Albin, Roger L., Greenamyre, J. Timothy·1992·Neurology

Open this paper in CoChat — free account

Abstract

It is known that asthma is a heterogeneous entity whose manifestations vary with age. Our objective was to examine changes in the manifestation of asthma and asthma-related traits in childhood by defining empirically derived childhood asthma phenotypes and examining their transitions over time. To define the phenotypes we used data on respiratory symptoms, healthcare utilisation, medications, spirometry, airway hyperresponsiveness (AHR), exhaled nitric oxide concentration and atopy from a birth cohort recruited on the basis of having a first-degree relative with asthma. Data were acquired at ages 1.5–11.5 years and analysed using latent transition analysis. In a study population of 370 participants, we classified subjects into four phenotypes: 1) nonatopic, few symptoms (prevalence range from 1.5 to 5 years: 52–60%), 2) atopic, few symptoms (3–21%), 3) nonatopic, asthma and rhinitis symptoms (13–35%), and 4) atopic, asthma and rhinitis symptoms (2–14%) in early childhood; and 1) nonatopic, no respiratory disease (prevalence range from 8 to 11.5 years: 41–46%), 2) atopic, no respiratory disease (23–33%), 3) nonatopic, asthma symptoms, no AHR or airway inflammation (8–12%) and 4) atopic asthma (19%) in mid-childhood. Transitioning between phenotypes was common in early childhood, but less common in later childhood. This analysis represents the first attempt to incorporate longitudinal patterns of several manifestations of asthma into a single model to simultaneously define phenotypes and examine their transitions over time. It provides quantitative support for the view that asthma is a heterogeneous entity, and that some children with wheeze and other respiratory symptoms in early life progress to asthma in mid-childhood, while others become asymptomatic.

Integrity signals

Registry

Crossref · 10.1212/wnl.42.4.733

Cites

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Sorted by citations

Items 401–500 of 573

The mitochondrial inhibitor malonate enhances NMDA toxicity in the neonatal rat striatum
Maragos, W. F., & Silverstein, F. S. (1995) · Developmental Brain Research · doi:10.1016/0165-3806(95)00085-r · Cited by 16
Therapeutic potential of NMDA antagonists in neurodegenerative diseases
McBurney, R. N. (1994) · Neurobiology of Aging · doi:10.1016/0197-4580(94)90131-7 · Cited by 16
Effect of different sample pretreatment methods on the concentrations of excitatory amino acids in cerebrospinal fluid determined by high-performance liquid chromatography
Zhang, H., Zhai, S., Li, Y. M., et al. (2002) · Journal of Chromatography B · doi:10.1016/s1570-0232(02)00788-2 · Cited by 15
Transplantation of GABAergic Cells Derived from Bioreactor-Expanded Human Neural Precursor Cells Restores Motor and Cognitive Behavioral Deficits in a Rodent Model of Huntington's Disease
McLeod, M., Kobayashi, N., Sen, A., Baghbaderani, B. A., Sadi, D., Ulalia, R., Behie, L. A., & Mendez, I. M. (2013) · Cell Transplantation · doi:10.3727/096368912x658809 · Cited by 15
Huntington's disease
Bonelli, R. M., & Beal, M. F. (2012) · Handbook of clinical neurology · doi:10.1016/b978-0-444-52002-9.00030-9 · Cited by 16
Different patterns of axonal damage after intracerebral injection of malonate or AMPA
Cuthill, D., Fowler, J. H., McCulloch, J., & Dewar, D. (2006) · Experimental Neurology · doi:10.1016/j.expneurol.2006.03.021 · Cited by 15
Advances in Huntington’s disease: implications for experimental therapeutics
Feigin, A. (1998) · Current Opinion in Neurology · doi:10.1097/00019052-199808000-00012 · Cited by 15
Rotenone increases glutamate‐induced dopamine release but does not affect hydroxyl‐free radical formation in rat striatum
Leng, A., Feldon, J., & Ferger, B. (2003) · Synapse · doi:10.1002/syn.10260 · Cited by 15
“Mitochondrial dysfunction has also been implicated in “secondary excitoxicity,” which may render nigral neurons more vulnerable to excitotoxic events (Albin and Greenamyre, 1992; Beal, 1992).”
Intelligence outcome of pediatric intensive care unit survivors: a systematic meta-analysis and meta-regression
de Sonnaville, E. S. V., Königs, M., van Leijden, O., Knoester, H., van Woensel, J. B. M., & Oosterlaan, J. (2022) · BMC Medicine · doi:10.1186/s12916-022-02390-5 · Cited by 14
Effect of hypothermia on postmortem alterations in MAP2 immunostaining in the human hippocampus
Kitamura, O., Gotohda, T., Ishigami, A., et al. (2004) · Legal Medicine · doi:10.1016/j.legalmed.2004.08.003 · Cited by 14
Neuroprotective and neurorestorative strategies for neuronal injury
Beal, M. F., Palomo, T., Kostrzewa, R. M., & Archer, T. (2000) · Neurotoxicity Research · doi:10.1007/bf03033786 · Cited by 14
Intrastriatal Neurotoxin Injections Reduce in Vitro and in Vivo Binding of Radiolabeled Rotenoids to Mitochondrial Complex I
Kilbourn, M. R., Charalambous, A., Frey, K. A., et al. (1997) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1097/00004647-199703000-00003 · Cited by 14
Self-citation
Introduction and Historical Notes
Beal, M. F. (2004) · Springer eBooks · doi:10.1007/978-1-4419-8959-8_1 · Cited by 13
Metabolism, Distribution and Excretion of a Selective N-Methyl-d-Aspartate Receptor Antagonist, Traxoprodil, in Rats and Dogs
Prakash, C., Cui, D., Potchoiba, M. J., et al. (2007) · Drug Metabolism and Disposition · doi:10.1124/dmd.107.016105 · Cited by 13
“In these latter conditions, subtle but chronic deregulation in neuronal energy metabolism renders neurons susceptible to excitotoxicity from physiological glutamate receptor activity (Maragos et al., 1987; Albin and Greenamyre, 1992; Green and Greenamyre, 1996).”
Background
A Multi-Scale Computational Model of Excitotoxic Loss of Dopaminergic Cells in Parkinson's Disease
Muddapu, V. R., & Chakravarthy, V. S. (2020) · Frontiers in Neuroinformatics · doi:10.3389/fninf.2020.00034 · Cited by 12
“The reason behind the lower percentage of surviving SNc cells at lower values of δCCB, δECP, and δASB might be due to “strong excitotoxicity” (Albin and Greenamyre, 1992).”
BackgroundInfluential
Synergistic effects of chronic exposure to subthreshold concentrations of quinolinic acid and malonate in the rat striatum
Bazzett, T. J., Falik, R. C., Becker, J. B., et al. (1996) · Brain Research · doi:10.1016/0006-8993(96)00143-6 · Cited by 13
Self-citation
Death of septal cholinergic neurons produced by chronic exposure to glutamate is prevented by the noncompetitive NMDA receptor/channel antagonist, MK‐801: Role of nerve growth factor and nitric oxide
Michel, P. P., & Agid, Y. (1995) · Journal of Neuroscience Research · doi:10.1002/jnr.490400608 · Cited by 13
A Cytotoxic, Co-operative Interaction Between Energy Deprivation and Glutamate Release From System x c − Mediates Aglycemic Neuronal Cell Death
Thorn, T. L., He, Y., Jackman, N. A., Lobner, D., Hewett, J. A., & Hewett, S. J. (2015) · ASN NEURO · doi:10.1177/1759091415614301 · Cited by 12
“Consequently, we set out to test whether the weak excitotoxic hypothesis (Albin and Greenamyre, 1992)—which posits that bioenergetic deficiencies enhance the toxic effect of glutamate—might explain the results described earlier.”
BackgroundResultInfluential
Chapter 19 Cellular delivery of trophic factors for the treatment of Huntington's disease: is neuroprotection possible?
Kordower, J. H., Isacson, O., Leventhal, L., et al. (2000) · Progress in brain research · doi:10.1016/s0079-6123(00)27020-9 · Cited by 12
Mechanisms of Neuronal Degeneration in Huntington’s Disease
Ferrante, R. J., Beal, M. F., & Kowall, N. W. (1994) · Advances in behavioral biology · doi:10.1007/978-1-4613-0485-2_15 · Cited by 12
Neuroprotective possibilities for Huntington’s disease
Emerich, D. F. (2001) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.1.3.467 · Cited by 12
CELL DAMAGE/EXCITOTOXICITY | Excitotoxicity and Neurodegenerative Disease
Tannenberg, R. K., & Dodd, P. R. (2009) · Elsevier eBooks · doi:10.1016/b978-012373961-2.00069-2 · Cited by 12
Age-related changes in rat cerebellar basket cells: a quantitative study using unbiased stereological methods
Henrique, R., Rocha, E., REIS, A., Marcos, R., OLIVEIRA, M. H., SILVA, M. W., & Monteiro, R. A. F. (2001) · Journal of Anatomy · doi:10.1046/j.1469-7580.2001.19860727.x · Cited by 11
“It is also noteworthy that even normal concentrations of glutamate can be neurotoxic, particularly when a neuron is metabolically compromised, namely by the changes that accompany the ageing process (Albin & Greenamyre, 1992).”
Background
Receptor Targets in Alzheimer’s Disease Drug Discovery
Wallach, J. V., Colestock, T., & Adejare, A. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-802810-0.00006-4 · Cited by 11
Cyclosporin A and Bcl-2 do not inhibit quinolinic acid-induced striatal excitotoxicity in rodents
Maciel, E. A. (2003) · Experimental Neurology · doi:10.1016/s0014-4886(03)00165-1 · Cited by 11
Long-term neurocognitive outcomes after pediatric intensive care: exploring the role of drug exposure
de Sonnaville, E. S. V., Oosterlaan, J., Ghiassi, S. A., van Leijden, O., van Ewijk, H., Knoester, H., van Woensel, J. B. M., & Königs, M. (2023) · Pediatric Research · doi:10.1038/s41390-022-02460-7 · Cited by 10
Effect of hypothermia on postmortem alterations in MAP2 immunostaining in the human hippocampus
Kitamura, O., Gotohda, T., Ishigami, A., et al. (2005) · Legal Medicine · doi:10.1016/j.legalmed.2005.08.006 · Cited by 10
Toxic animal models
Przedborski, S., & Tieu, K. (2005) · Cambridge University Press eBooks · doi:10.1017/cbo9780511544873.017 · Cited by 10
A Multi-Scale Computational Model of Levodopa-Induced Toxicity in Parkinson's Disease
Muddapu, V. R., Vijayakumar, K., Ramakrishnan, K., & Chakravarthy, V. S. (2022) · Frontiers in Neuroscience · doi:10.3389/fnins.2022.797127 · Cited by 9
“Due to disinhibition and energy deﬁciency, SNc somas might become overactive, which leads to a calcium build-up, resulting in excitotoxic loss of SNc somas (Albin and Greenamyre, 1992; Muddapu et al., 2019).”
Background
Molecular and Cellular Events Regulating Dopamine Neuron Survival
Corsini, G. U., Maggio, R., & Vaglini, F. (2002) · Handbook of experimental pharmacology · doi:10.1007/978-3-662-06765-9_11 · Cited by 9
Glutamatergic and GABAergic metabolite levels in Alzheimer’s disease: a systematic review and meta-analysis
Ebrahimi, R., Soltani, S. M., Masouri, M. M., Seifi, M., Ghafourian, K., & Noori, S. (2025) · BMC Neurology · doi:10.1186/s12883-025-04375-2 · Cited by 11
“Damage to glutamatergic neurons, especially in cortical and hippocampal regions, is a well-established feature of AD pathology [108], alongside altered expression of glutamate transporters and receptors [109, 110].”
Therapeutic Approaches to Non-Motor Symptoms of Parkinson's Disease: A Current Update on Preclinical Evidence
Weerasinghe-Mudiyanselage, P. D. E., Kang, S., Kim, J., & Moon, C. (2022) · Current Neuropharmacology · doi:10.2174/1570159x20666221005090126 · Cited by 8
“Furthermore, glutamate excitotoxicity is involved in the degeneration of DAergic neurons in PD [198].”
Background
Mitochondria and Parkinson's Disease
Simon, D. K., Chu, C. T., & Swerdlow, R. H. (2011) · Parkinson s Disease · doi:10.4061/2011/261791 · Cited by 8
Transformation of Brain Structure and Spiritual Experience
Newberg, A. B. (2012) · Oxford University Press eBooks · doi:10.1093/oxfordhb/9780199729920.013.0031 · Cited by 8
Excitatory Amino Acid-Induced Degeneration of Dendrites of Catecholamine Neurons in Rat Substantia Nigra
Johnson, S. M., & Bywood, P. T. (1998) · Experimental Neurology · doi:10.1006/exnr.1998.6783 · Cited by 8
Neurotoxic Effects of Kainic Acid on Substantia Nigra Neurons in Rat Brain Slices
Johnson, S. M., Luo, X., & Bywood, P. T. (1997) · Experimental Neurology · doi:10.1006/exnr.1997.6578 · Cited by 8
NEUROTOXIC MECHANISMS OF DEGENERATION IN MOTOR NEURON DISEASES*
Ludolph, A. C., & Münch, C. (1999) · Drug Metabolism Reviews · doi:10.1081/dmr-100101938 · Cited by 8
Role of corticostriatal and nigrostriatal inputs in malonate-induced striatal toxicity
Meldrum, A., Dunnett, S. B., & Everitt, B. J. (2001) · Neuroreport · doi:10.1097/00001756-200101220-00025 · Cited by 8
Harmonic activity of glutamate dehydrogenase and neuroplasticity: The impact on aging, cognitive dysfunction, and neurodegeneration
Salarvandian, S., Digaleh, H., Khodagholi, F., Javadpour, P., Asadi, S., Zaman, A. A. O., & Dargahi, L. (2024) · Behavioural Brain Research · doi:10.1016/j.bbr.2024.115399 · Cited by 7
Parkinson’s Disease
Burke, R. E. (1999) · Humana Press eBooks · doi:10.1007/978-1-4612-1602-5_22 · Cited by 12
Differential expression of α-amino-3-hydroxy-5-methyl-4-isoxazolepropionate receptor subunits by calretinin-immunoreactive neurons in the human striatum
Cicchetti, F., Vinet, J., Beach, T. G., & Parent, A. (1999) · Neuroscience · doi:10.1016/s0306-4522(99)00110-4 · Cited by 7
Bioenergetics and excitotoxicity
Greene, J. G., & Greenamyre, J. T. (1996) · Elsevier eBooks · doi:10.1016/b978-012525445-8/50010-2 · Cited by 7
Self-citation
Perimenopausal state oestradiol to progesterone imbalance drives Alzheimer’s risk via ERRα dysregulation and energy dyshomeostasis
Sun, J. K., Peng, A. Z., Hart, R. P., Herrup, K., Wu, D., Wong, G. C., & Chow, H. (2025) · Nature Communications · doi:10.1038/s41467-025-66726-4 · Cited by 7
Survey of Selective Neurotoxins
Kostrzewa, R. M. (2014) · Springer eBooks · doi:10.1007/978-1-4614-5836-4_53 · Cited by 6
Long-Term Follow-Up of Daily Life Functioning After Pediatric Intensive Care Unit Admission
de Sonnaville, E. S. V., Königs, M., Aarnoudse-Moens, C. S. H., van Woensel, J. B. M., Oosterlaan, J., & Knoester, H. (2023) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2023.113477 · Cited by 6
Endoplasmic reticulum stress induces Alzheimer disease‐like phenotypes in the neuron derived from the induced pluripotent stem cell with D678H mutation on amyloid precursor protein
Devina, T., Wong, Y., Hsiao, C., Li, Y., Lien, C., & Cheng, I. H.-J. (2022) · Journal of Neurochemistry · doi:10.1111/jnc.15687 · Cited by 9
“We chose to differentiate our iPSCs into the glutamatergic excitatory neurons because a significantly decreased number of glutamatergic neurons in the postmortem AD brain has been reported previously (Albin & Greenamyre, 1992; Mountjoy et al., 1983).”
Quantitative determination of glycine in commercial dosage forms by kinetic spectrophotometry
Mitić, S., Pavlovic, A. N., Tošić, S., et al. (2009) · Journal of Analytical Chemistry · doi:10.1134/s1061934809070053 · Cited by 6
Effects of Intermittent Hypoxia on Neurological Function
Gozal, D. (2009) · Contemporary clinical neuroscience · doi:10.1007/978-1-60327-579-8_9 · Cited by 6
Does the cerebral cortex exacerbate dopaminergic cell death in the substantia nigra of 6OHDA-lesioned rats?
Luquin, N., & Mitrofanis, J. (2007) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2007.08.010 · Cited by 6
Novel glycineB antagonists show neuroprotective activityin vivo
Wenk, G. L., Baker, L. M., Hauss-Wegrzyniakl, B., Danysz, W., & Stoehr, J. D. (1998) · Amino Acids · doi:10.1007/bf01345266 · Cited by 6
Time-Course Analysis and Comparison of Acute and Chronic Intrastriatal Quinolinic Acid Administration on Forelimb Reaching Deficits in the Rat
Bazzett, T. J., Legnard, E., Bauter, M. R., et al. (1999) · Experimental Neurology · doi:10.1006/exnr.1999.7070 · Cited by 6
Self-citation
Chorea Huntington Tiermodelle eröffnen neue Hypothesen zu Pathophysiologie und Therapie
Kosinski, C., Cha, J.-H. J., Young, A. B., & Schwarz, M. (1999) · Der Nervenarzt · doi:10.1007/pl00002778 · Cited by 6
“durch teilweise Dekortikation oder durch Gabe von Antagonisten exzitatorischer Aminosäuren [1].”
BackgroundInfluential
Perspectives for Ginsenosides in Models of Parkinson's Disease
Wei-Ming, L. (2007) · Journal of Ginseng Research · doi:10.5142/jgr.2007.31.3.127 · Cited by 5
El núcleo subtalámico en la fisiopatología de la enfermedad de Parkinson y su rol como diana quirúrgica
Herrera, C. R. M. (2011) · Revista chilena de neuro-psiquiatría · doi:10.4067/s0717-92272011000100008 · Cited by 5
Concentration-dependent changes in motor behavior produced by continuous intrathecal infusion of excitatory amino acids in the rat spinal cord
Nakamura, R., Kamakura, K., Hirata, A., et al. (1997) · Brain Research Protocols · doi:10.1016/s1385-299x(97)00015-9 · Cited by 5
Age-Dependent Mechanisms of White Matter Injury After Stroke
Baltan, S. (2013) · Springer eBooks · doi:10.1007/978-1-4614-9123-1_16 · Cited by 6
Malonic Acid and the Chronic Administration Model of Excitotoxicity
Bazzett, T. J., Albin, R. L., & Becker, J. B. (2000) · Humana Press eBooks · doi:10.1007/978-1-59259-692-8_15 · Cited by 5
Self-citation
The spatial and temporal relationship between oxidative stress and neuronal degeneration in 3-nitropropionic acid model
Delorme, T., Najafi, M., & Nasr, P. (2012) · World Journal of Neuroscience · doi:10.4236/wjns.2012.24036 · Cited by 5
Delayed Neuronal Degeneration Results from Endogenous Glutamate Excess
Volpe, B. T. (1997) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1997.tb48390.x · Cited by 5
Effects of Taurine Deficiency and Chronic Methanol Administration on Rat Retina, Optic Nerve and Brain Amino Acids and Monoamines
González‐Quevedo, A., Obregón, F., Urbina, M., et al. (2003) · Nutritional Neuroscience · doi:10.1080/1028415031000151558 · Cited by 5
“Increased Asp levels have been involved in the pathogenesis of various neurological diseases (Albin and Greenamyre, 1992; Nieborj-Dobosz and Janik, 1999).”
Background
New Therapeutic Approaches for the Treatment of Huntington’s Disease
Mazurová, Y. (2001) · Acta Medica (Hradec Kralove Czech Republic) · doi:10.14712/18059694.2019.97 · Cited by 5
Neurodegenerative diseases and memory
Wenk, G. L. (2007) · Elsevier eBooks · doi:10.1016/b978-012372540-0/50017-0 · Cited by 5
“…conditions, subsequent activation of NMDA receptors by ordinary glutamatergic synaptic activity could permit a continuous "leak" of calcium ions into neurons, theoretically overwhelming the endogenous mechanisms that regulate calcium ion homeostasis (Choi et al., 1987; Albin and Greenamyre, 1992).”
Background
Excitatory amino acid neurotoxicity--a broader horizon for cerebral protection?
Tasker, R. C. (1992) · Archives of Disease in Childhood · doi:10.1136/adc.67.11.1327 · Cited by 5
A computational model of loss of dopaminergic cells in Parkinson’s disease due to glutamate-induced excitotoxicityPreprint
Muddapu, V. R., Mandali, A., Chakravarthy, V. S., et al. (2018) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/385138 · Cited by 5
A Computational Model of Levodopa-Induced Toxicity in Substantia Nigra Pars Compacta in Parkinson’s DiseasePreprint
Muddapu, V. R., Vijayakumar, K., Ramakrishnan, K., & Chakravarthy, V. S. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.04.05.026807 · Cited by 5
“s) which are already in a low energy state. Due to disinhibition and energy deficiency, SNc somas might become overactive, which leads to calcium build-up, resulting in excitotoxic loss of SNc somas (Albin and Greenamyre, 1992; Muddapu et al., 2019). When higher concentrations of extracellular LDOPA were available, th…”
BackgroundResult
Therapeutic effects of nitric oxide synthase inhibition in neuronal injury
Beal, M. F. (1996) · Elsevier eBooks · doi:10.1016/b978-012525445-8/50008-4 · Cited by 5
Daily intranasal resveratrol-conjugated gold nanoparticles administration promotes neuroprotection and improves neurological outcome in the R6/2 mouse model of Huntington's disease
Paldino, E., Montalesi, E., Fiocchetti, M., Dioguardi, F., Venditti, I., Olivieri, E., Marino, M., & Fusco, F. R. (2026) · Experimental Neurology · doi:10.1016/j.expneurol.2026.115639 · Cited by 4
Alterations in the transcriptional profile of genes related to glutamatergic signalling in animal models of Alzheimer’s disease. The effect of fingolimod
Sułkowski, G., Wencel, P. L., Dąbrowska‐Bouta, B., Strużyńska, L., & Strosznajder, R. P. (2022) · Folia Neuropathologica · doi:10.5114/fn.2022.114302 · Cited by 4
Caffeine and Parkinson’s Disease
Nehlig, A. (2004) · CRC Press eBooks · doi:10.1201/9780203618851-17 · Cited by 5
A neurotheological perspective on altered states of consciousness
Newberg, A. B., & Yaden, D. B. (2018) · Journal of Consciousness Studies · Cited by 4
Use of genetically engineered mice as models for exploring the role of oxidative stress in neurodegenerative diseases
Andersen, J. K. (1998) · Frontiers in bioscience · doi:10.2741/a259 · Cited by 4
New Therapeutic Approaches: Rationale and Results
Mitsumoto, H. (1995) · Springer eBooks · doi:10.1007/978-1-4471-1871-8_18 · Cited by 4
Drug treatments to reduce excitotoxicity in vivo : a potential for α 2 -adrenoceptor antagonists?
Martel, J.-C., Chopin, P., Colpaert, F. C., & Marien, M. R. (2000) · Amino Acids · doi:10.1007/s007260070055 · Cited by 4
“Excitotoxicity is promoted and potentiated by cellular energy impairment (Novelli et al., 1988; Albin and Greenamyre, 1992; Beal et al., 1993; Turski and Turski, 1993).”
Background
Predicting long-term neurocognitive outcome after pediatric intensive care unit admission for bronchiolitis—preliminary exploration of the potential of machine learning
de Sonnaville, E. S. V., Vermeule, J., Oostra, K., Knoester, H., van Woensel, J. B. M., Allouch, S. B., Oosterlaan, J., & Königs, M. (2023) · European Journal of Pediatrics · doi:10.1007/s00431-023-05307-3 · Cited by 3
“…with mechanical ventilation, and metabolic derangements may have negatively affected children’s neurocognitive outcome after PICU admission [12–14, 63 Although prevention strategies, such as respiratory syncytial virus vaccine in pregnancy [64], show promising results, children will…”
Background
Bioenergetics in Oxidative Damage in Neurodegenerative Diseases
Beal, M. F. (1996) · Springer eBooks · doi:10.1007/978-1-4899-0209-2_22 · Cited by 3
Dopamine Neurotoxicity and Neurodegeneration
McLaughlin, B. (2001) · Humana Press eBooks · doi:10.1007/978-1-59259-006-3_9 · Cited by 3
Amantadine and anticholinergics
Dashtipour, K., Chung, J. S., Wu, A. D., et al. (2013) · CRC Press eBooks · doi:10.1201/b14361-21 · Cited by 3
Neuroprotective Mechanisms: Oxidative Stress as a Target for Neuroprotective Therapies in Alzheimer's and Parkinson's Disease
Huber, A., Bürkle, A., & Münch, G. W. (2007) · Springer eBooks · doi:10.1007/978-0-387-30377-2_6 · Cited by 3
Mechanisms of Neuronal Death in Huntington's Disease
Koliatsos, V. E., Portera‐Cailliau, C., Schilling, G., Borchelt, D. B., Bêcher, M. W., & Ross, C. A. (2001) · Humana Press eBooks · doi:10.1007/978-1-59259-106-0_5 · Cited by 4
Síndrome de Parkinson: Revisión bibliográfica y actualización
Zambrano, C. R. V., Jiménez, R. A. J., Rodríguez, V. E. M., et al. (2020) · RECIMUNDO · doi:10.26820/recimundo/4.(4).octubre.2020.270-281 · Cited by 3
Gene and Protein Expression and Regulation in the Central Nervous System
Leszek, K., Gozal, D., & Czyzyk-Krzeska, M. (2002) · CRC Press eBooks · doi:10.1201/9780203910504-11 · Cited by 3
The Role of Glutamine and Glutamic Acid in the Pituitary Gland Involvement in Thyroid-Stimulating Hormone Release
Aizawa, S., Sakai, T., & Sakata, I. (2014) · Springer eBooks · doi:10.1007/978-1-4939-1932-1_5 · Cited by 2
Role of Ionotropic Glutamate Receptors in Neurodegenerative and Other Disorders
Ragnarsson, L. K. N., Dodd, P. R., & Hynd, M. R. (2014) · Springer eBooks · doi:10.1007/978-1-4614-5836-4_144 · Cited by 3
Excitotoxicity
Henchcliffe, C., & Beal, M. F. (2007) · Handbook of clinical neurology · doi:10.1016/s0072-9752(07)83027-2 · Cited by 2
Neuroprotective effect of memantine on serum S100-B levels after on-pump coronary artery bypass graft surgery: A randomized clinical trial.
Tabary, S. Z., Tabary, P. Z., & Motlagh, A. S. (2022) · PubMed · doi:10.22088/cjim.13.2.412 · Cited by 2
“Increase in glutamate concentration leads to an increase in neuronal excitability through these receptors which in turn trigger the process of neuronal apoptosis (6-8).”
Background
Amantadine and anticholinergics
Dashtipour, K., Chung, J. S., Wu, A. D., et al. (2013) · Informa Healthcare eBooks · doi:10.3109/9781841849096.018 · Cited by 2
Haz prerrúbrico de Papez y zona incierta caudal en la enfermedad de Parkinson
Zurita-Cueva, B., Villamar, F., Cornejo, P., Clara Bedoya, P., Altamirano, J. F., Navarrete-Carreño, M., & Carreño, O. N. (2009) · NeuroTarget · doi:10.47924/neurotarget2009320 · Cited by 2
Excitotoxicity*
Lau, A., & Tymianski, M. (2010) · Elsevier eBooks · doi:10.1016/b978-0-08-046884-6.01331-2 · Cited by 2
Apoptosis in Huntington disease and animal models
Koliatsos, V. E., Portera‐Cailliau, C., Schilling, G., Borchelt, D. B., Bêcher, M. W., & Ross, C. A. (2001) · Advances in cell aging and gerontology · doi:10.1016/s1566-3124(01)06008-4 · Cited by 2
Therapeutics in Huntington’s Disease
Rosas, H. D., & Koroshetz, W. J. (2002) · Handbook of experimental pharmacology · doi:10.1007/978-3-662-06274-6_17 · Cited by 2
Cellular Delivery of Neurotrophic Factors as a Potential Treatment for Huntington's Disease
Emerich, D. F., Kordower, J. H., & Ole Isacson, A. (1999) · Elsevier eBooks · doi:10.1016/b978-012705070-6/50019-6 · Cited by 2
7-nitroindazole, a selective neuronal nitric oxide synthase inhibitore in vivo, prevents kainate-induced intrahippocampal neurotoxicity
Radenović, L., Selaković, V., & Nedeljković, B. B. (2005) · Archives of Biological Sciences · doi:10.2298/abs0502075r · Cited by 2
Retracted
Transplantation of Encapsulated Cells into the Central Nervous System
Sagen, J., Bruhn, S. L., Rein, D. H., et al. (1999) · Birkhäuser Boston eBooks · doi:10.1007/978-1-4612-1586-8_28 · Cited by 2
Systemic Administration of 3-Nitropropionic Acid
Brouillet, E., Hantraye, P., & Beal, M. F. (2000) · Humana Press eBooks · doi:10.1007/978-1-59259-691-1_16 · Cited by 2
Cortical brain release of glutamate by ketamine and fluoxetine: An in vivo microdialysis study in the Flinders Sensitive Line rat
Visser, G. P. (2012) · Boloka Institutional Repository (North-west University) · Cited by 2
Huntington’s Disease and DRPLA: Two Glutamine Repeat Diseases
Ross, C. A., Bêcher, M. W., & Koliatsos, V. E. (1999) · Humana Press eBooks · doi:10.1007/978-1-4612-1602-5_23 · Cited by 2
Schizophrenia and Mitochondrial Dysfunction
Akarsu, S. (2014) · Psikiyatride Guncel Yaklasimlar - Current Approaches in Psychiatry · doi:10.5455/cap.20140121114707 · Cited by 1
Mitochondrial Dysfunction and Neurodegenerative Diseases
Lin, M., & Beal, M. F. (1998) · Springer eBooks · doi:10.1007/978-3-662-12509-0_13 · Cited by 1
Conotoxins: Possible Therapeutic Measure for Huntingtons Disease
Vaibhav, P. B. S. (2013) · Journal of Neurological Disorders · doi:10.4172/2329-6895.1000129 · Cited by 1
Intermittent Hypoxia During Sleep as a Model of Environmental (Nongenetic) Contributions to Attention Deficit Hyperactivity Disorder
Row, B. W., & Gozal, D. (2005) · Contemporary clinical neuroscience · doi:10.1385/1-59259-891-9:131 · Cited by 1

Authors: Albin, R. L., & Greenamyre, J. T.
Affiliations: University of Michigan (US)
University of Rochester (US)
ORCID: Albin, Roger L.
Greenamyre, J. Timothy
Venue: Neurology
Publisher: Ovid Technologies (Wolters Kluwer Health)
Published: 1992-04
Volume: 42
Issue: 4
Pages: 733-733
ISSN: 0028-3878 (ISSN-L)
1526-632X
DOI: 10.1212/wnl.42.4.733
OpenAlex: W2058176457
Cited by: 574
References: 0
Citations by year: 2026: 1 · 2025: 3 · 2024: 6 · 2023: 3 · 2022: 18 · 2021: 4 · 2020: 12 · 2019: 3 · 2018: 6 · 2017: 7 · 2016: 5 · 2015: 4 · 2014: 10 · 2013: 12 · 2012: 16
FWCI: 14.01
Type: journal article
Language: en
Open access: closed
Locations: Neurology (publishedVersion)
PubMed (publishedVersion)
Funders: National Institutes of Health (5k08ns001300-03, 5k08ns001487-03)
National Institute of Neurological Disorders and Stroke (NS01300, NS 01487)
Topics: Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Asthma and respiratory diseases
Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Occupational exposure and asthma
Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Respiratory and Cough-Related Research
Keywords: asthma phenotypes, childhood asthma, asthma heterogeneity, phenotype transition, atopy, rhinitis, airway hyperresponsiveness, exhaled nitric oxide, wheezing, latent transition analysis, birth cohort
MeSH terms: Acute Disease, Amino Acids, Chronic Disease, Humans, Models, Neurological, Nerve Degeneration, Nervous System Diseases, Neurology, Neurotoxins, Receptors, Cell Surface, Receptors, Amino Acid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Alternative excitotoxic hypotheses

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cited by

Related

Metadata

Record

About these checks